|2005N-0354||Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing|
|FDA Comment Number :||EC54|
|Submitter :||Dr. Toby Watson||Date & Time:||12/07/2005 06:12:57|
|Organization :||Associated Psychological Health Services|
|Category :||Health Care Association|
| Psychiatric drug advertisements clearly are unethical since they continue to present false and misleading modes of action, effectiveness and side effect data. I would urge the FDA to require all mass media advertisements that are made to the direct public be 'passed' or 'approved' by the FDA to ensure they do not continue to mislead and cause harm to individuals. I urge the reader of this comment to read the article recently published on SSRI Advertisements (J. Lacasse and J. Leo, Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature, In PLos Medicine, December, 2005, vol. 2, issue 12, e392, or see it online at http://medicine.plosjournals.org/
%2Epmed%2E0020392). This article outlines my concern better than any other single published article I have found.
Dr. Toby Watson, PsyD